Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Phio Pharmaceuticals stock
Learn how to easily invest in Phio Pharmaceuticals stock.
Phio Pharmaceuticals is a biotechnology business based in the US. Phio Pharmaceuticals shares (PHIO) are listed on the NASDAQ and all prices are listed in US Dollars. Phio Pharmaceuticals employs 12 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Phio Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PHIO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Phio Pharmaceuticals stock price (NASDAQ: PHIO)Use our graph to track the performance of PHIO stocks over time.
Phio Pharmaceuticals shares at a glance
|Latest market close||$6.16|
|52-week range||$3.90 - $29.04|
|50-day moving average||$5.31|
|200-day moving average||$7.68|
|Wall St. target price||$72.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.92|
Buy Phio Pharmaceuticals stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Phio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Phio Pharmaceuticals price performance over time
|1 week (2023-01-31)||-1.00%|
|1 month (2023-01-06)||909.84%|
|3 months (2022-11-08)||976.92%|
|6 months (2022-08-08)||742.68%|
|1 year (2022-02-08)||601.59%|
|2 years (2021-02-08)||77.01%|
|3 years (2020-02-07)||7.45|
|5 years (2018-02-07)||2257.198|
Phio Pharmaceuticals financials
|Gross profit TTM||$-8,886,000|
|Return on assets TTM||-34.82%|
|Return on equity TTM||-62.93%|
|Market capitalisation||$7 million|
TTM: trailing 12 months
Phio Pharmaceuticals share dividends
We're not expecting Phio Pharmaceuticals to pay a dividend over the next 12 months.
Have Phio Pharmaceuticals's shares ever split?
Phio Pharmaceuticals's shares were split on a 1:12 basis on 25 January 2023. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Phio Pharmaceuticals shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Phio Pharmaceuticals shares which in turn could have impacted Phio Pharmaceuticals's share price.
Phio Pharmaceuticals share price volatility
Over the last 12 months, Phio Pharmaceuticals's shares have ranged in value from as little as $3.9 up to $29.04. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phio Pharmaceuticals's is 1.3983. This would suggest that Phio Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Phio Pharmaceuticals overview
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp.
Frequently asked questionsWhat percentage of Phio Pharmaceuticals is owned by insiders or institutions?
Currently 1.073% of Phio Pharmaceuticals shares are held by insiders and 5.324% by institutions. How many people work for Phio Pharmaceuticals?
Latest data suggests 12 work at Phio Pharmaceuticals. When does the fiscal year end for Phio Pharmaceuticals?
Phio Pharmaceuticals's fiscal year ends in December. Where is Phio Pharmaceuticals based?
Phio Pharmaceuticals's address is: 257 Simarano Drive, Marlborough, MA, United States, 01752 What is Phio Pharmaceuticals's ISIN number?
Phio Pharmaceuticals's international securities identification number is: US71880W3034 What is Phio Pharmaceuticals's CUSIP number?
Phio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 74979C105
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert